Cargando…
Stromal remodeling by the BET bromodomain inhibitor JQ1 suppresses the progression of human pancreatic cancer
Inhibitors of bromodomain and extraterminal domain (BET) proteins, a family of chromatin reader proteins, have therapeutic efficacy against various malignancies. However, the detailed mechanisms underlying the anti-tumor effects in distinct tumor types remain elusive. Here, we show a novel antitumor...
Autores principales: | Yamamoto, Keisuke, Tateishi, Keisuke, Kudo, Yotaro, Hoshikawa, Mayumi, Tanaka, Mariko, Nakatsuka, Takuma, Fujiwara, Hiroaki, Miyabayashi, Koji, Takahashi, Ryota, Tanaka, Yasuo, Ijichi, Hideaki, Nakai, Yousuke, Isayama, Hiroyuki, Morishita, Yasuyuki, Aoki, Taku, Sakamoto, Yoshihiro, Hasegawa, Kiyoshi, Kokudo, Norihiro, Fukayama, Masashi, Koike, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5308665/ https://www.ncbi.nlm.nih.gov/pubmed/27528027 http://dx.doi.org/10.18632/oncotarget.11129 |
Ejemplares similares
-
Isocitrate dehydrogenase 1 mutation sensitizes intrahepatic cholangiocarcinoma to the BET inhibitor JQ1
por: Fujiwara, Hiroaki, et al.
Publicado: (2018) -
Soluble VCAM-1 promotes gemcitabine resistance via macrophage infiltration and predicts therapeutic response in pancreatic cancer
por: Takahashi, Ryota, et al.
Publicado: (2020) -
BET bromodomain inhibitor (JQ1) and tumor angiogenesis
por: Bid, Hemant Kumar, et al.
Publicado: (2016) -
Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation
por: Fujiwara, Hiroaki, et al.
Publicado: (2019) -
HNF1B‐driven three‐dimensional chromatin structure for molecular classification in pancreatic cancers
por: Kato, Hiroyuki, et al.
Publicado: (2022)